Shandong Lukang International Trading Co., Ltd. (600789) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
16 Pages - GLDATA55968
$250.00

Summary

Shandong Lukang International Trading Co., Ltd (Shandong Lukang) is a pharmaceutical company that manufactures and markets pharmaceuticals for human use and intermediates, and veterinary use. The company’s human pharmaceuticals and intermediates include ampicillin trihydrate powder, ceftriaxone sodium sterile, azlocillin sodium sterile, penicillin g sodium sterile, mezlocillin acid, cefazolin acid and meropenem. It offers veterinary pharmaceuticals such as tylosin base, natamycin, ceftiofur sodium sterile and pleuromutilin. Shandong Lukang provides other preparations such as spectinomycin hcl, benzylpenicillin sodium, streptomycin sulphate, ampicillin sodium, cefradine, ceftriaxone sodium, cefoxitin sodium, cefalexin and cefradine. The company offers products in the form of powder, capsules, tablets, granules and drysuspensions. Shandong Lukang is headquartered in Jining, China.

Shandong Lukang International Trading Co., Ltd. (600789) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 8
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Shandong Lukang Pharma And Shandong Zoucheng Economic Development Zone To Form Joint Venture 9
Shandong Lukang Pharma To Form Joint Venture With Shandong-Based Medicine Company 10
Acquisition 11
Shandong Lukang Pharma To Sell 60% Stake In Environmental Protection Technology Subsidiary 11
Shandong Lukang Record Pharma To Acquire 70% Stake In Qinghai Earth Pharma For US$6.6 Million 12
Shandong Lukang Pharma To Sell 32.5% Stake In Medicine Company 13
Shandong Lukang International Trading Co., Ltd. - Key Competitors 14
Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Key Facts, 2014 1
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 1
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 8
Shandong Lukang Pharma And Shandong Zoucheng Economic Development Zone To Form Joint Venture 9
Shandong Lukang Pharma To Form Joint Venture With Shandong-Based Medicine Company 10
Shandong Lukang Pharma To Sell 60% Stake In Environmental Protection Technology Subsidiary 11
Shandong Lukang Record Pharma To Acquire 70% Stake In Qinghai Earth Pharma For US$6.6 Million 12
Shandong Lukang Pharma To Sell 32.5% Stake In Medicine Company 13
Shandong Lukang International Trading Co., Ltd., Key Competitors 14

List of Figures
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Shandong Lukang International Trading Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838